Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThg Regulatory News (THG)

Share Price Information for Thg (THG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 64.00
Bid: 0.00
Ask: 65.00
Change: 0.00 (0.00%)
Spread: 1.45 (2.282%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 64.00
THG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

THG acquires luxury skincare brand Perricone MD

30 Sep 2020 07:00

RNS Number : 5100A
THG Holdings PLC
30 September 2020
 

30th September 2020

 

THG Holdings plc

 

THG ACQUIRES LUXURY SKINCARE BRAND PERRICONE MD

 

Acquisition further strengthens THG's leadership in specialty beauty retailing

 

THG Holdings plc ("THG" or the "Group"), the global technology platform company, specialising in taking brands direct to consumers, today announces the acquisition of Perricone MD, a pre-eminent US prestige skincare brand, for $60 million in cash.

 

Founded in 1997, Perricone MD is a science-led topical skincare brand. Its skincare formulations and supplements address a broad range of dermatological needs, supported by extensive clinical and consumer studies. The brand has approximately 100 product patents and is committed to no-animal testing, clean ingredients and gluten free formulations.

 

As the digital-strategic leader in the beauty market, the Group is able to be extremely selective with acquisitions and it has acquired 100% of Perricone MD for a 1x continuing sales multiple. Perricone MD is profitable at the EBITDA level although THG anticipates minimal impact in the current financial year. As Perricone MD is transitioned by THG Ingenuity into a digital-first and global brand it is expected to be earnings accretive by the end of the financial year 2021, achieving double digit EBITDA margins consistent with previous THG Beauty brand acquisitions.

 

Perricone MD will join the Group's Beauty portfolio of own brands, which includes ESPA, Christophe Robin, Grow Gorgeous, Illamasqua, Mio Skincare, Mama Mio, Eyeko and Ameliorate.

 

"Perricone MD has a strong heritage, a loyal customer base and is a truly exciting addition to THG's beauty portfolio," said Matthew Moulding, Founder, Chairman and CEO of THG. "The online beauty and skincare sector is growing rapidly, and this acquisition enables us to further strengthen our position as the world's leading pure-play speciality beauty brand owner and retailer."

THG's stated Beauty M&A strategy is to acquire industry-leading brands and intellectual property, typically constrained by store-based retail channels and limited geographic reach. Through immediate implementation of THG's Ingenuity Platform, Brands gain direct access to consumers across the globe. This enables THG's Brands to reach a truly global audience, whilst directly controlling every element of the consumer experience and delivering materially accretive margins.

 

Mr. Moulding added: "Perricone MD will now benefit from the powerful and sustainable infrastructure of THG Ingenuity, which has a proven track record of scaling revenues and enhancing the margins of acquired brands."

 

THG has been executing this own brand beauty acquisition strategy for the last four years, with over 50% of revenues across its existing portfolio of seven existing beauty brands now generated from direct-to-consumer sales globally online.

 

Lookfantastic has been an important long-term partner for Perricone MD, enabling THG to build a significant understanding of the brand over many years. In the last 12 months, Perricone MD has seen very significant sales growth on Lookfantastic, which has given further confidence in the acquisition rationale of the brand.

 

Immediately post acquisition, THG will launch Perricone MD on its THG Ingenuity technology platform, delivering the following benefits:

 

· A proprietary, end-to-end platform: trading, merchandising, marketing, real-time data

· 14 THG fulfilment centres globally, powered by proprietary management software

· 180+ integrated couriers reaching 195+ destinations, with express delivery for key markets

· 29 data centres globally ensuring rapid website speeds across all key markets

· 50+ payment options across 40 currencies, localising consumer payment options

· 7 content studios delivering digital brand building and content creation (THG Studios)

· In-house digital marketing and a proprietary influencer platform (THG Society)

· 6,000 native linguist network delivering specialised translation services (THG Fluently)

· Proprietary fraud prevention platform, featuring device fingerprinting, data matching against known fraud, API capability and business intelligence tools (THG Detect)

· International customer service, with integrated translation services and with communication via email, live chat, iMessage, WhatsApp, Weibo, ABC, Revoo and other local platforms

· In-house product development and manufacturing (BRC A Grade, FDA-approved)

 

In line with THG's broader strategy, the Group also remains focused on making investments across technology, sustainability and infrastructure. The purpose of these investments will be to further enhance its unique-end-to-end ecommerce platform, delivering digital and sustainability transformation programmes for 3rd party brands, in addition to powering THG's own brands.

 

THG intends to report its first trading update (covering Q3 2020) to the market on 26th October 2020.

 

ENDS

 

For more information, please contact:

 

THG

For investor enquiries, Matt Rothwell

 

 

For media enquiries, Viki Tahmasebi

 

Matt.Rothwell@thehutgroup.com

+44 7788 334 569

 

Viki.Tahmasebi@thg.com

+44 7966 028 340

 

 

Instinctif Partners

(Public relations advisor to THG)

Guy Scarborough

Damian Reece

 

 

+44 7917 178 920

+44 7931 598 593

 

Notes to Editors

 

About THG

 

THG is an international online retailer and technology company. Founded in 2004 by CEO Matthew Moulding, Manchester-based THG now operates 200+ localised websites, retailing goods in 169 countries. In the year to 31 December 2019, the Group grew sales by 24% to £1.14bn, with 66% of sales generated internationally. More than half of THG's sales come from its own brand products. THG owns Lookfantastic and Myprotein amongst other brands operating primarily in the beauty and wellbeing sector.

 

About THG Ingenuity

 

THG Ingenuity is THG's end-to-end ecommerce platform, powering THG's own business as well as those of brands and retailers around the world. THG Ingenuity comprises access to THG's international infrastructure across warehouse fulfilment, digital content studios and event spaces, an end-to-end proprietary software solution required to operate and scale retail brands, and a suite of in-house consultative and management services across trading, marketing and brand strategy. It is one of the only platforms that is underpinned by proven expertise as it has demonstrably scaled brands globally and now powers 3rd party brands on a SAAS basis.

 

THG Ingenuity is partnered with leading retailers across the globe, including Groupe L'Occitane, PZ Cussons Beauty and Nintendo. THG Ingenuity helped the Group dispatch over 80 million items during the year ended 31 December 2019 to customers across the world and saw THG reach the top of the Sunday Times profit track for two consecutive years.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQSEAESUESSEEU
Date   Source Headline
1st May 20247:01 amRNSBlock Listing Six Monthly Return
1st May 20247:00 amRNSTotal Voting Rights
29th Apr 20247:00 amRNSAnnual Report & Accounts 2023
26th Apr 202410:31 amRNSDirector/PDMR Shareholding
23rd Apr 20247:00 amRNSQ1 2024 Trading Statement
22nd Apr 20244:31 pmRNSNotice of Q1 Trading Update
10th Apr 20247:00 amRNSPreliminary FY 2023 results
2nd Apr 20247:00 amRNSTotal Voting Rights
15th Mar 20247:00 amRNSDirectorate Change
13th Mar 20247:00 amRNSApplication for Listing and Total Voting Rights
7th Mar 20244:15 pmRNSGrant of Share Options
4th Mar 20247:00 amRNSRevolving Credit Facility extension to May 2026
1st Mar 20247:00 amRNSTotal Voting Rights
1st Feb 20247:00 amRNSTotal Voting Rights
16th Jan 20247:01 amRNSQ4 Trading Statement
16th Jan 20247:00 amRNSIngenuity fulfilment partnership
2nd Jan 20247:00 amRNSTVR & 2023 AGM Voting Outcome Update
5th Dec 20237:00 amRNSAcquisition of Biossance
4th Dec 20237:00 amRNSTotal Voting Rights
1st Nov 20237:01 amRNSBlock Listing Six Monthly Returns
1st Nov 20237:00 amRNSTotal Voting Rights
17th Oct 20237:00 amRNSQ3 2023 Trading Statement
2nd Oct 20237:00 amRNSTotal Voting Rights
14th Sep 20237:00 amRNSInterim results for the half-year ended 30 June 23
1st Sep 20237:00 amRNSNotice of Results
1st Aug 20237:00 amRNSTotal Voting Rights
21st Jul 20237:00 amRNSStrategic review update
3rd Jul 20237:00 amRNSTotal Voting Rights
23rd Jun 20237:00 amRNSPDMR-PCA Shareholdings
23rd Jun 20237:00 amRNSPDMR / PCA Shareholdings
22nd Jun 202311:31 amRNSPDMR/PCA Shareholdings
21st Jun 20232:55 pmRNSResult of AGM
21st Jun 20237:01 amRNSChanges to Board Composition
21st Jun 20237:00 amRNSAGM Trading Statement
18th May 20234:00 pmRNSNotice of AGM
18th May 20238:35 amRNSForm 8.5 (EPT/NON-RI) THG PLC Amendment
18th May 20238:33 amRNSForm 8.5 (EPT/NON-RI) THG PLC Amendment
17th May 20237:16 amRNSForm 8.5 (EPT/NON-RI) THG PLC amendment
17th May 20237:15 amRNSForm 8.5 (EPT/NON-RI) THG PLC amendment
15th May 20233:20 pmRNSForm 8.3 - THG plc
15th May 20239:59 amRNSForm 8.5 (EPT/NON-RI) THG PLC
12th May 20239:30 amRNSForm 8.5 (EPT/RI)
12th May 20237:30 amRNSRule 2.8 Announcement
12th May 20237:00 amRNSTermination of discussions with Apollo
11th May 20233:20 pmRNSForm 8.3 - THG plc
11th May 202310:09 amRNSForm 8.5 (EPT/NON-RI) THG PLC
11th May 20239:13 amRNSForm 8.5 (EPT/RI)
11th May 20238:26 amRNSForm 8.5 (EPT/NON-RI) THG Plc
10th May 202312:51 pmEQSForm 8.3 - The Vanguard Group, Inc.: THG PLC
10th May 202311:50 amRNSForm 8.5 (EPT/NON-RI) THG plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.